Scholars Central

Conference abstractPublished 2 Aug 2018

Artificial neural network algorithms for biomarker discovery and pathway modeling

Authors: Graham Ball

Nottingham Trent University, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer is a complex disease with a myriad of forms and prognoses occurring within each type. For example, in breast cancer using genomic profiling in excess of 80 sub types have been identified. The ability to characterize the disease for each patient may offer the potential to assess the molecular sub-type of the disease and thus accurately determine the patientsâ?? prognostic outcome. Methodologies such as mass spectrometry-based proteomics, RNASeq and gene expression arrays offer the potential for characterization of disease derived samples using a huge number of proteins or genes. This depth of information while providing a comprehensive overview of a disease state also proves problematic in its complexity. One has to search through potentially hundreds of thousands of pieces of information for consistent features that address a clinical question in the population. The human mind is very good at finding patterns in a system but is not able to conduct the task repetitively for large numbers of parameters. Conversely computers are very good at searching for features in such a data space, but previously defined statistical methods are not able to cope with the high complexity. Here, we present the application of Artificial Neural Networks (ANNs, a form of artificial intelligence having the characteristics of both human pattern recognition and computer automated searching) to finding genomic solutions to questions in cancer. Here, we present the use of a range of statistical and artificial intelligence-based machine learning techniques to develop prognostic models for breast cancer. Here, we present results of use of ANN algorithms for biomarker discovery, whereby we have undertaken a parallel analysis of multiple molecular databases for breast cancer and have identified markers that drive proliferation and thus predict response to anthracycline.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Graham Ball”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels